Form 8-K - Current report:
SEC Accession No. 0001193125-25-151254
Filing Date
2025-06-27
Accepted
2025-06-27 16:05:55
Documents
13
Period of Report
2025-06-26
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d12458d8k.htm   iXBRL 8-K 37331
  Complete submission text file 0001193125-25-151254.txt   186766

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rvmdw-20250626.xsd EX-101.SCH 4431
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rvmdw-20250626_def.xml EX-101.DEF 13422
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rvmdw-20250626_lab.xml EX-101.LAB 22326
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rvmdw-20250626_pre.xml EX-101.PRE 14326
15 EXTRACTED XBRL INSTANCE DOCUMENT d12458d8k_htm.xml XML 5908
Mailing Address 700 SAGINAW DR REDWOOD CITY CA 94063
Business Address 700 SAGINAW DR REDWOOD CITY CA 94063 415-766-3638
Revolution Medicines, Inc. (Filer) CIK: 0001628171 (see all company filings)

EIN.: 472029180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39219 | Film No.: 251086283
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)